WallStSmart

Akso Health Group ADR (AHG)vsMcKesson Corporation (MCK)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

McKesson Corporation generates 3027611% more annual revenue ($418.79B vs $13.83M). MCK leads profitability with a 1.1% profit margin vs -135.0%. MCK earns a higher WallStSmart Score of 49/100 (D+).

AHG

Avoid

12

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 5.3Quality: 9.0
Piotroski: 5/9Altman Z: 12.00

MCK

Hold

49

out of 100

Grade: D+

Growth: 7.3Profit: 4.5Value: 4.0Quality: 7.0
Piotroski: 5/9Altman Z: 5.40
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AHGUndervalued (+8.4%)

Margin of Safety

+8.4%

Fair Value

$1.54

Current Price

$1.33

$0.21 discount

UndervaluedFair: $1.54Overvalued
MCKSignificantly Overvalued (-54.6%)

Margin of Safety

-54.6%

Fair Value

$616.65

Current Price

$1105.04

$488.39 premium

UndervaluedFair: $616.65Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHG2 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
12.0010/10

Safe zone — low bankruptcy risk

MCK4 strengths · Avg: 9.3/10
Debt/EquityHealth
-2.8210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
5.4010/10

Safe zone — low bankruptcy risk

Market CapQuality
$124.35B9/10

Large-cap with strong market position

Free Cash FlowQuality
$2.95B8/10

Generating 2.9B in free cash flow

Areas to Watch

AHG4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.16B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-89.4%2/10

ROE of -89.4% — below average capital efficiency

Revenue GrowthGrowth
-12.9%2/10

Revenue declined 12.9%

MCK4 concerns · Avg: 3.5/10
PEG RatioValuation
1.864/10

Expensive relative to growth rate

P/E RatioValuation
27.8x4/10

Moderate valuation

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
1.1%3/10

1.1% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : AHG

The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.

Bull Case : MCK

The strongest argument for MCK centers on Debt/Equity, Altman Z-Score, Market Cap.

Bear Case : AHG

The primary concerns for AHG are EPS Growth, Market Cap, Return on Equity.

Bear Case : MCK

The primary concerns for MCK are PEG Ratio, P/E Ratio, Return on Equity. Thin 1.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

AHG profiles as a turnaround stock while MCK is a value play — different risk/reward profiles.

MCK carries more volatility with a beta of 0.28 — expect wider price swings.

MCK is growing revenue faster at 7.6% — sustainability is the question.

MCK generates stronger free cash flow (2.9B), providing more financial flexibility.

Bottom Line

MCK scores higher overall (49/100 vs 12/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Akso Health Group ADR

HEALTHCARE · MEDICAL DISTRIBUTION · China

Akso Health Group ADR is a leading entity in the healthcare sector, dedicated to providing innovative medical solutions and comprehensive patient care services. With a strong emphasis on advanced health technologies, the company is strategically positioned in the telehealth and personalized medicine markets, supported by a robust research and development framework. As it navigates the rapidly evolving healthcare landscape, Akso Health Group presents an attractive investment opportunity for institutional investors seeking to capitalize on transformative trends within the industry.

Visit Website →

McKesson Corporation

HEALTHCARE · MEDICAL DISTRIBUTION · USA

McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

Visit Website →

Want to dig deeper into these stocks?